variant gp120 polypeptide vaccine (NIH OTT)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namevariant gp120 polypeptide vaccine (NIH OTT)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines
Mechanisms of ActionHIV envelope protein gp120 modulators
TargetsHIV envelope protein gp120
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A